discorhabdin-l and Leukemia-P388

discorhabdin-l has been researched along with Leukemia-P388* in 1 studies

Other Studies

1 other study(ies) available for discorhabdin-l and Leukemia-P388

Article	Year
Discorhabdin W, the first dimeric discorhabdin. Journal of natural products, 2005, Volume: 68, Issue:12 Discorhabdin W (1), isolated from a New Zealand Latrunculia sp. sponge, is a symmetrical dimer with potent in vitro activity against the P388 murine leukemia cell line. The structure and stereochemistry were assigned by using 1D- and 2D-NMR experiments and mass spectrometry. Discorhabdins B (2), D (3), G/I (4), and L (5) were also isolated from the same sponge. Topics: Animals; Antineoplastic Agents; Leukemia P388; Molecular Structure; New Zealand; Nuclear Magnetic Resonance, Biomolecular; Porifera; Quinones; Spiro Compounds; Thiazepines; Tumor Cells, Cultured	2005

Article

Year

Discorhabdin W, the first dimeric discorhabdin.

Journal of natural products, 2005, Volume: 68, Issue:12

Discorhabdin W (1), isolated from a New Zealand Latrunculia sp. sponge, is a symmetrical dimer with potent in vitro activity against the P388 murine leukemia cell line. The structure and stereochemistry were assigned by using 1D- and 2D-NMR experiments and mass spectrometry. Discorhabdins B (2), D (3), G/I (4), and L (5) were also isolated from the same sponge.

Topics: Animals; Antineoplastic Agents; Leukemia P388; Molecular Structure; New Zealand; Nuclear Magnetic Resonance, Biomolecular; Porifera; Quinones; Spiro Compounds; Thiazepines; Tumor Cells, Cultured

2005